Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
2 results
Filters applied: . Clear all
Page 1
Exploring extracellular matrix and prostaglandin pathway alterations across varying resection margin distances of right-sided colonic adenocarcinoma.
BMC Cancer. 2023 Dec 7;23(1):1202. doi: 10.1186/s12885-023-11595-7.
BMC Cancer. 2023.
PMID: 38062443
Free PMC article.
BACKGROUND: Surgical resection followed by indicated adjuvant therapy offers potential curative treatment in colonic adenocarcinoma. Beyond the well-established seed and soil theory of colon cancer progression, the 'normal-appearing' tissues near the tumor are not genuinel …
BACKGROUND: Surgical resection followed by indicated adjuvant therapy offers potential curative treatment in colonic adenocarcinoma. Beyond …
The KRAS-Mutant Consensus Molecular Subtype 3 Reveals an Immunosuppressive Tumor Microenvironment in Colorectal Cancer.
Tanjak P, Chaiboonchoe A, Suwatthanarak T, Acharayothin O, Thanormjit K, Chanthercrob J, Suwatthanarak T, Wannasuphaphol B, Chumchuen K, Suktitipat B, Sampattavanich S, Korphaisarn K, Pongpaibul A, Poungvarin N, Grove H, Riansuwan W, Trakarnsanga A, Methasate A, Pithukpakorn M, Chinswangwatanakul V.
Tanjak P, et al.
Cancers (Basel). 2023 Feb 8;15(4):1098. doi: 10.3390/cancers15041098.
Cancers (Basel). 2023.
PMID: 36831441
Free PMC article.
Colorectal cancers (CRC) with KRAS mutations (KRAS(mut)) are frequently included in consensus molecular subtype 3 (CMS3) with profound metabolic deregulation. ...
Colorectal cancers (CRC) with KRAS mutations (KRAS(mut)) are frequently included in consensus molecular subtype 3 (CMS3) with profoun …
Item in Clipboard
Cite
Cite